Prescribing information

 

Nurse support with ongoing monitoring of patients treated with MAYZENT.

About the MayzentConnect nurses

Our MayzentConnect nurse team have experience caring for a wide range of patients, including patients with MS, and have in-depth knowledge of MAYZENT. Once MAYZENT has been prescribed, our nurse team can provide first-dose observation and ongoing monitoring.
 

How can MayzentConnect support the ongoing monitoring of patients treated with MAYZENT?

Help optimise treatment adherence
The MayzentConnect nurse can reinforce the importance of taking each MAYZENT dose and call patients daily during the titration period.

Offer ongoing contact and reliable support
The MayzentConnect nurse will be an additional point of contact for patients to discuss support needs and personal challenges.

 

Provide ongoing monitoring and personalised feedback
The MayzentConnect nurse can periodically collect blood samples and check in with patients.
Questionnaire responses and general discussion will help to create personalised support.

 
 

Indication: MAYZENT is indicated for the treatment of adult patients with SPMS with active disease evidenced by relapses or imaging features of inflammatory activity.1

MS, multiple sclerosis; SPMS, secondary progressive multiple sclerosis.

Reference

  1. MAYZENT (siponimod) Summary of Product Characteristics.
SIP20-C001f May 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the patient safety information (PSI) tool at https://psi.novartis.com
If you have a question about the product, please contact Medical Information on 01276 692255 or by email at [email protected]